BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

Leukemia, Published online: 19 August 2019; doi:10.1038/s41375-019-0540-7BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications

https://www.nature.com/articles/s41375-019-0540-7

Source: Leukemia - August 18, 2019 Category: Hematology Authors: Jooeun Bae Neha Parayath Wenxue Ma Mansoor Amiji Nikhil Munshi Kenneth Anderson Source Type: research

More News: Hematology | Leukemia | Myeloma | Nanotechnology